WT1 and mesothelioma: The specificity of the TCR could be more accurately assessed if the reactivity of the WT1 epitope-specific TCR was assessed using mesothelioma cells expressing MHC-I, WT1 antigen, and IP, such as MESO-4 and HMMME.